Showing 1 - 10 of 87
We analyse the determinants of opposition to biotechnology and pharmaceutical patents granted by the European Patent Office between 1978–96. Opposition can be considered an early form of patent validity challenge suit. In our sample, 8.6% of the patents are attacked in opposition proceedings....
Persistent link: https://www.econbiz.de/10005791233
Persistent link: https://www.econbiz.de/10003363610
Persistent link: https://www.econbiz.de/10001689654
Persistent link: https://www.econbiz.de/10001731940
Persistent link: https://www.econbiz.de/10013259896
We present a theoretical and empirical analysis of the fitness of national German (German Commercial Code - Handelsgesetzbuch (HGB)) and international (IAS and US-GAAP) accounting information, as well as European patent data to explain the market values of German manufacturing firms. For the...
Persistent link: https://www.econbiz.de/10010295644
Persistent link: https://www.econbiz.de/10003412751
Persistent link: https://www.econbiz.de/10011403946
Persistent link: https://www.econbiz.de/10011973588
We present a theoretical and empirical analysis of the fitness of national German (German Commercial Code - Handelsgesetzbuch (HGB)) and international (IAS and US-GAAP) accounting information, as well as European patent data to explain the market values of German manufacturing firms. For the...
Persistent link: https://www.econbiz.de/10005083258